Arcturus Therapeutics Holdings Inc. (ARCT)

ARCT Revenue

Arcturus Therapeutics Holdings had revenue of $28.30M in the quarter ending June 30, 2025, a decrease of -43.24%. This brings the company's revenue in the last twelve months to $122.12M, down -25.47% year-over-year. In the year 2024, Arcturus Therapeutics Holdings had annual revenue of $152.31M, down -8.69%.

• Revenue (ttm): $122.12M
• Revenue Growth: -25.47%
• P/S Ratio: 3.30
• Revenue / Employee: $693,875
• Employees: 176
• Market Cap: 521.51M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	152.31M	-14.49M	-8.69%
Dec 31, 2023	166.80M	-39.20M	-19.03%
Dec 31, 2022	206.00M	193.64M	1,566.79%
Dec 31, 2021	12.36M	2.82M	29.56%
Dec 31, 2020	9.54M	-11.25M	-54.12%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.